Abudounaibi Abudoueryimu | Medicine | Best Researcher Award

Best Researcher Award

Abudounaibi Abudoueryimu  – Kashi Prefecture Second People’s Hospital, China

Researcher Information
Affiliation Kashi Prefecture Second People’s Hospital
Country China
Scopus ID 60622239600
Documents 1
Subject Area Medicine
Event Scientific World Research Awards

The Best Researcher Award recognizes researchers who demonstrate scholarly excellence, scientific integrity, and meaningful contributions within their respective disciplines. Abudounaibi Abudoueryimu, affiliated with Kashi Prefecture Second People’s Hospital, has established an academic profile in the field of Medicine. The researcher’s documented scholarly output indexed by Scopus reflects participation in international scientific communication and contributes to the advancement of evidence-based medical research.[1]

Abstract

Abudounaibi Abudoueryimu is associated with Kashi Prefecture Second People’s Hospital and has an indexed research profile in Medicine. Recognition through the Best Researcher Award acknowledges scholarly activity, publication quality, and commitment to advancing clinical knowledge. Academic evaluation for such recognition commonly considers publication records, scientific relevance, ethical research practices, and contributions to healthcare improvement.[1]

Keywords

  • Medicine
  • Clinical Research
  • Scientific Publications
  • Healthcare
  • Evidence-Based Medicine
  • Scopus
  • Best Researcher Award

Introduction

Modern medical research integrates clinical practice, scientific investigation, and interdisciplinary collaboration to improve patient outcomes. Researchers working within hospital environments contribute to diagnostic innovation, therapeutic development, and healthcare quality through evidence-driven investigations. Scholarly recognition programs highlight researchers whose work demonstrates academic merit and professional commitment.[2]

Research Profile

Abudounaibi Abudoueryimu is affiliated with Kashi Prefecture Second People’s Hospital in China and maintains an indexed Scopus author profile (Author ID: 60622239600). The available bibliographic information indicates scholarly participation within the field of Medicine. Institutional affiliation with a clinical healthcare facility supports the integration of patient-centered research and practical medical applications.[1]

Research Contributions

Research contributions are commonly assessed through originality, methodological rigor, publication quality, and scientific relevance. The research profile demonstrates participation in peer-reviewed scientific communication indexed by international bibliographic databases. Such contributions support the dissemination of medical knowledge and encourage further clinical investigation.[1]

Publications

  • Indexed publication(s) available through the Scopus Author Profile.
  • Publication metadata includes peer-reviewed scholarly records indexed by Elsevier Scopus.
  • Associated DOI information is available where assigned by the publisher.

Research Impact

Research impact extends beyond publication counts and includes scientific visibility, citation influence, knowledge dissemination, and clinical relevance. Indexing within internationally recognized databases enhances discoverability and facilitates academic collaboration among researchers across healthcare disciplines.[2]

Award Suitability

Based on the available scholarly profile, Abudounaibi Abudoueryimu demonstrates characteristics that are relevant to consideration for the Best Researcher Award, including indexed academic publications, institutional research affiliation, and participation in medical scholarship. Final award decisions should be determined through comprehensive evaluation of publication quality, research significance, citation metrics, peer recognition, and ethical scientific conduct.[1]

Conclusion

Abudounaibi Abudoueryimu’s academic profile reflects ongoing engagement in medical research through internationally indexed scholarly publications. Recognition within the Scientific World Research Awards framework highlights the importance of sustained scientific excellence, responsible research practices, and contributions that support continuous advancement in medicine and healthcare.[2]

 

References

  1. Elsevier. (n.d.). Scopus author details: Abudounaibi Abudoueryimu, Author ID 60622239600. Scopus.

    https://www.scopus.com/pages/authors/60622239600
  2. Bibliometric Analysis and Research Trends of MRI Findings in Placenta Previa.
    https://www.researchgate.net/publication/402597301_Bibliometric_Analysis_and_Research_Trends_of_MRI_Findings_in_Placenta_Previa

Liang Liu | Medicine | Best Researcher Award

Best Researcher Award

Researcher Information
Researcher Liang Liu
Affiliation Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University
Country China
Scopus ID 56543839300
Documents 206
Citations 6763
h-index 45
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-7826-3877

Liang Liu – Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University

Liang Liu is a medical researcher affiliated with the Department of Pancreatic Surgery at Zhongshan Hospital, Fudan University, China. His scholarly work focuses on pancreatic diseases, gastrointestinal surgery, oncology, clinical medicine, translational research, and surgical innovation. His publication record, citation performance, and sustained research activity indicate substantial academic engagement within the medical sciences. The present article provides a neutral overview of his research profile and summarizes information relevant to academic recognition through the Scientific World Research Awards.[1]

Abstract

Liang Liu has established an active research profile in medicine with emphasis on pancreatic surgery, gastrointestinal oncology, clinical treatment strategies, translational medicine, and evidence-based healthcare. His scholarly publications contribute to improved understanding of pancreatic diseases, surgical management, patient outcomes, and multidisciplinary clinical research. Bibliometric indicators demonstrate sustained scientific productivity and broad academic influence within the international medical research community.[1]

Keywords

  • Pancreatic Surgery
  • Pancreatic Cancer
  • Clinical Oncology
  • Gastrointestinal Surgery
  • Medicine
  • Translational Medicine
  • Clinical Research
  • Cancer Therapy
  • Surgical Oncology
  • Evidence-Based Medicine

Introduction

Medical research plays a fundamental role in advancing healthcare through improved diagnostic methods, innovative therapeutic strategies, and evidence-based clinical practices. Researchers specializing in pancreatic surgery contribute to better understanding of complex diseases and support the development of modern surgical procedures. Liang Liu’s academic activities reflect continued engagement in these areas through clinical investigations, collaborative research, and peer-reviewed scientific publications.[2]

Research Profile

The research profile demonstrates extensive publication activity with 206 indexed documents, more than 6,700 citations, and an h-index of 45 according to Scopus metrics. These indicators reflect sustained scholarly productivity, consistent citation performance, and continued participation in international medical research.[1]

  • Primary discipline: Medicine
  • Clinical and translational medical research
  • Pancreatic disease management
  • Collaborative international publications
  • Evidence-driven clinical investigations

Research Contributions

Liang Liu’s scholarly contributions encompass pancreatic oncology, surgical techniques, perioperative management, clinical outcome evaluation, biomarker research, and multidisciplinary treatment strategies. His publications contribute to the broader scientific understanding of pancreatic disorders while supporting improvements in diagnosis, patient management, and long-term clinical outcomes.[2]

Publications

Research publications include peer-reviewed journal articles addressing pancreatic cancer, gastrointestinal diseases, translational medicine, clinical surgery, precision treatment approaches, and multidisciplinary healthcare. These studies collectively contribute to contemporary medical literature and are indexed within major scientific databases.[3]

  • Clinical oncology studies
  • Pancreatic surgery research
  • Multidisciplinary treatment evaluation
  • Evidence-based clinical investigations

Research Impact

Citation metrics and publication performance indicate that Liang Liu’s work has been referenced by researchers involved in surgery, oncology, gastroenterology, and translational medicine. Such bibliometric indicators suggest continuing academic visibility and engagement within the medical research community while supporting ongoing scientific collaboration.[1]

Award Suitability

Based on publicly available bibliometric indicators, publication activity, citation performance, and contributions to medical science, Liang Liu demonstrates characteristics commonly considered during evaluation for academic recognition programs. Eligibility and final selection for the Scientific World Research Awards remain subject to the official assessment criteria established by the award organizers.[4]

Conclusion

Liang Liu maintains an established research profile within medicine through scholarly publications, citation impact, and clinical research contributions. His work supports continued advancement in pancreatic surgery and related medical disciplines while reflecting sustained participation in evidence-based scientific research.[1]

References

  1. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    https://www.sciencedirect.com/science/article/abs/pii/S0304419X22000014
  2. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
    https://www.researchgate.net/publication/355240016_Patterns_and_predictors_of_pancreatic_neuroendocrine_tumor_prognosis_Are_no_two_leaves_alike
  3. Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    https://www.sciencedirect.com/science/article/abs/pii/S1530891X21011794
  4. Scientific World Research Awards.
    https://scientificworld.net/

Lina Posada Calderon | Medicine | Research Excellence Award

Dr. Lina Posada Calderon | Medicine | Research Excellence Award

Resident | New York Presbyterian | United States

Dr. Lina Posada Calderon is an accomplished biomedical researcher at Weill Cornell Medicine, New York, specializing in translational and molecular cancer research. Her work focuses on the clinical and molecular characterization of cancers, precision oncology, biomarker discovery, and genetic drivers of tumor progression, with particular emphasis on KRAS-mutated malignancies. She has strong expertise in molecular biology, cancer genomics, clinical data analysis, interdisciplinary research, and high-impact scientific publishing. Her research bridges laboratory discoveries with patient-centered clinical outcomes. Dr. Posada Calderon has published 12 Scopus-indexed documents, receiving 61 citations, and holds an h-index of 5, reflecting her growing scholarly impact and emerging leadership in precision cancer research.

 

Citation Metrics (Scopus)

61
45
30
15
0

Citations

61

Documents

12

h-index

5

Citations

Documents

h-index

View Scopus Profile
View Google Scholar

Featured Publications

 

Dimitrios Tsiachris | Medicine | Best Researcher Award

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.